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Breast cancer is a disease of modern life. As societies industrialize, risk increases, yet it is unclear
which of the myriad changes coming with industrialization drives this increase. One important
hallmark of modern life is the pervasive use of electric power. Electric power produces light at
night (LAN) and electric and magnetic fields (EMF), either or both of which may alter pineal
function and its primary hormone melatonin, thereby, perhaps increasing the risk of breast
cancer. This hypothesis, stated a decade ago, is now receiving considerable experimental and
epidemiological attention. The circumstantial case for the hypothesis has three aspects: light
effects on melatonin, EMF effects on melatonin, and melatonin effects on breast cancer. The
strongest of these aspects is the effects of light on melatonin. It is clear that the normal nocturnal
melatonin rise in humans can be suppressed by light of sufficient intensity. The evidence for an
effect of melatonin on breast cancer in experimental animals is strong, but the evidence in
humans is scant and difficult to gather. The weakest aspect of the circumstantial case is EMF
effects on melatonin. Whereas a half dozen independent laboratories have published findings of
suppression in animals, there are inconsistencies, and there are no published data on humans.
The direct evidence bearing on the hypothesis is sparse but provocative. Two laboratories have
published data showing substantial increases in chemically induced breast cancer in rats by a
weak AC (alternating current) magnetic field. The epidemiological evidence is very limited but has
offered some support as well. An effect of electric power on breast cancer would have profound
implications, and this possibility deserves continued investigation. Environ Health Perspect
104(Suppl 1):135-140 (1996)
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Introduction
Breast cancer is the leading cause ofcancer
death in women in industrialized coun-
tries. Incidence rates, and to some extent
mortality, are increasing worldwide (1,2).
The assumption that the cause of these
increases is the change from indigenous
diets to the high-fat western diet has been
challenged by recent evidence showing no
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relationship between adult fat consump-
tion and breast cancer risk (3). Given the
conflicting evidence, the role ofadult con-
sumption of dietary fat in breast cancer
etiology, if any, is unclear. High energy
intake in childhood may be important (4)
but is difficult to study epidemiologically.
Recent enthusiasm for estrogenic chemi-
cals in the environment as an important
determinant ofrisk (5) has also been tem-
pered by recent studies (6) and biological
considerations (7).
Something about industrialization
seems to increase risk ofbreast cancer. But
which ofthe changes brought by industri-
alization is responsible? The generation,
distribution, and use ofelectric power is a
hallmark of modern life. Electric power
results in human exposure to light at night
(LAN) and anthropogenic (including
50/60 Hz) electric and magnetic fields
(EMF). These are relatively new exposures
in the human environment and, in modern
society, virtually everyone is exposed to
some extent. Could electric power be
implicated in the high rates of breast can-
cer in industrialized nations? The reason to
consider this suggestion is the possible
reduction of melatonin by LAN and/or
EMF (8-10). Melatonin, in turn, has a
strong inhibitory effect on breast cancer in
animals (11). The relative importance of
melatonin disruption in the etiology of
breast cancer in humans is not yet clear.
The Circumstantial Case
There are three aspects to the circum-
stantial case: the effect oflight on produc-
tion of melatonin, the effect of EMF on
production of melatonin, and the role of
melatonin in breast cancer.
LightEffects onMelatonin
The effect of light on pineal function in
humans has been extensively studied (12).
Several features oflight's effect are relevant
to the melatonin hypothesis for a connec-
tion between electric power and breast
cancer: a) the effect is qualitatively similar
to the effect in other mammals in that
sufficient intensity of nocturnal illumina-
tion suppresses melatonin production to
daytime levels (13,14); b) some people are
much more sensitive than others (15);
c) blue-green light is most effective in
reducing melatonin production, whereas
red light has little or no effect (16,17);
d) there appears to be a dose-response rela-
tionship with light (18) from minimal sup-
pression at 200 lux to maximal suppression
at 3,000 lux (the brighter the light the
greater the reduction in circulating mela-
tonin); and e) the effect oflight at night can
be seen in humans within 15 min (14,18).
The normal melatonin rhythm in
humans has characteristics that may be rel-
evant to breast cancer risk (19). The rise of
melatonin at night is not dependent on the
sleep/wake state; ifthe light level is dim, a
person will maintain a normal rhythm even
if he or she is awake all night. There are
large interindividual differences in total 24-
hr melatonin production, although each
person's rhythm is quite stable from night
to night. A person's usual 24-hr melatonin
production is not dependent on his/her
usual sleep length per night. Usual sleep
length per night is, however, positively cor-
related with the percent ofthe 24-hr mela-
tonin production that occurs at night. An
interesting question that has not so far
been answered is whether individual sensi-
tivity is related to usual melatonin rhythm,
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e.g., do those who are most sensitive to the
suppressive effects of nocturnal illumina-
tion also have a low (or high) normal mela-
tonin peak at night or a total production
over 24 hr?
It is not clear whether the intensity of
night-time light typically found in bed-
room environments at night (several lux or
less) has any effect on melatonin produc-
tion. The ambient nocturnal illumination
may be inadequate to affect pineal function
at all, particularly during sleep when the
eyelids are shut, further reducing retinal
illumination from bedroom light intensity.
In animals, very brieflight exposure (min-
utes or even seconds) at night can suppress
melatonin production (20); however,
extension ofillumination by use ofelectric
lighting into the night before sleep and
brief exposure to bright light during the
night may or may not have chronic effects
on melatonin that are relevant to breast
cancer risk in humans. Effects will depend
on the intensity oflight and the sensitivity
ofthe individual.
Effects ofElectricandMagnetic
Fields onMelatonin
The first reports that the pineal body might
respond to an artificial EMF appeared in the
early 1980s. Semm et al. (21) measured
electrical activity of pineal cells in anes-
thetized male guinea pigs. They found that
some pineal cells showed a drop in activity
upon application ofa static magnetic field
generated by two Helmholtz coils posi-
tioned around the head to provide an addi-
tion orsubtraction to thevertical component
ofthe geomagnetic field. Wilson et al. (22)
reported that exposure ofrats to a 60-Hz
electric field suppressed the normal noctur-
nal rise in pineal melatonin production in
male Sprague-Dawley-derived rats.
Since the Semm et al. (21) and Wilson
et al. (22) publications, there have been
additional reports that melatonin can be
suppressed byAC electric fields (23), rapid
changes in a static magnetic field (24-27),
and AC magnetic fields (28-30). There
have also been reports that such fields have
little or no effect (31-33). AC magnetic
fields as low as 10 mG have been reported
to suppress melatonin in rats (29,30). The
differences among experimental reports
may result from real differences in the
effectiveness ofthe fields employed in each
experiment, from artifacts associated with
the EMF exposures, such as noise or other
stress that account for a reduction ofmela-
tonin production in those experiments
claiming to show effects of EMF; or from
real effects on melatonin that are some-
times masked by natural biological variabil-
ity. Because the various laboratories
reporting effects are experienced in mela-
tonin research and have experience or
expert assistance in EMF dosimetry, the
possibility that artifact accounts for all of
the positive effects seems unlikely.
It is unclear whether EMF can affect
melatonin in humans, and several laborato-
ries are currently pursuing the question.
Typical ambient AC magnetic fields away
from appliances in people's homes are in the
1 to 2 mG range (34). The weight ofevi-
dence supports the position that an artificial
EMF can lower melatonin in some animal
species undersome exposure conditions.
MelatoninandBreast Cancer
Manipulation ofmelatonin levels has been
found to affect development ofseveral dif-
ferent cancer types in animals including
breast cancer, prostate cancer, and
melanoma (11). In particular, melatonin
injection has been reported to inhibit
chemically induced mammary tumor devel-
opment in rats, and pinealectomy enhances
it in both the DMBA model (35) and the
N-nitroso-N-methylurea (NMU) model
(36). There are several mechanistic inter-
pretations ofthese observations (37). Two
of these interpretations-that melatonin
may slow development and turnover ofthe
normal mammary cells at risk ofmalignant
transformation and that melatonin may be
directly oncostatic-act at opposite ends
ofthe carcinogenic process. For epidemio-
logical studies, the oncostatic capability of
melatonin is far more tractable because
recent exposures that lower melatonin
level would be relevant; ifmelatonin slows
development of normal cells that are at
risk, exposures in the very distant past
would be relevant and correspondingly
much more difficult to estimate.
Night-time plasma melatonin levels
have been reported to be lower in women
with estrogen receptor positive (ER+) breast
cancer than in ER negative (-) breast can-
cer and in healthycontrol women (38) and
lower in cases of primary breast cancer
than in women with benign breast disease
(39). In contrast, daytime melatonin was
found to be higher in breast cancer
patients in one report (40). It is difficult
to assess the meaning of these findings
due to the presence ofdisease and its pos-
sible effect on melatonin levels. It is
difficult to determine whether low noctur-
nal melatonin predisposes to increased
risk ofbreast cancer in women. Clarifying
the role of melatonin in normal and
malignant growth ofbreast tissue may pro-
vide a better understanding ofthe roles of
estrogen and prolactin in the etiology of
breast cancer.
The Direct Evidence
ExperimentalEvidence
Shah et al. (41) reported that constant
light increased DMBA-induced mammary
tumorigenesis in rats. Constant light effec-
tively suppresses melatonin production by
the pineal gland. At 55 days of age, rats
exposed to constant light from birth
showed a greater concentration ofterminal
end buds and alveolar buds in mammary
tissue than did rats raised on a 10-hr
light:14-hr dark regimen. Animals exposed
to constant light also showed greater DNA
synthesis activity in the mammary tissue
and higher levels ofcirculating prolactin. A
suggested mechanism for these results is that
reduced melatonin resulted in increased cir-
culating estrogen and prolactin and, conse-
quently, increased turnover of the breast
epithelial stem cells at risk of malignant
transformation (41,42).
The first report of an EMF-mammary
cancer experiment to appear in the peer-
reviewed literature was published in late
1991 by Beniashvili et al. (43). Magnetic
field exposure increased mammary cancer
incidence in rats treated with NMU com-
pared to NMU-treated rats not exposed to
the field (controls). There were 50 female
rats in each of five groups treated with
NMU at 55 days of age. The first four
groups were exposed to either a 50-Hz mag-
netic field or a static field for 30 min/day or
3 hr/day. The rats were followed for 2 years.
All exposed groups developed more mam-
mary tumors than the unexposed group 5,
and the mean time to appearance offirst
tumor was shorter. The group exposed to a
50-Hz magnetic field for 3 hr/day devel-
oped mammary tumors in 43 of its mem-
bers, whereas in the control group only 27
developed tumors; there were 75 total
tumors in the exposed group and 31 in the
unexposed group (p<0.05). Five more
groups of rats were studied in which no
NMU was used. No tumors developed in
50 control rats over the 2-year studyperiod,
whereas seven tumors appeared in 25 rats
exposed to the 50-Hz magnetic field for 3
hr/day. The results of Beniashvili et al.
(43) are striking; this is the first publica-
tion, positive or negative, describing the
direct influence of EMF on mammary
tumor induction in an animal model.
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L6scher et al. (44) performed a similar
experiment using a 1-G 50-Hz magnetic
field and 20 mg of DMBA. These authors
also reported a significant increase in mam-
mary tumor induction in rats exposed to
the field. Given the high 20-mg dose, 35 of
99 control animals developed palpable
mammary tumors within 13 weeks of
treatment. Among 99 exposed rats, 53
developed tumors (p<0.05). The size of
tumors was also significantly larger in the
exposed animals. L6scher's laboratory has
repeated these experiments and has also
published a series ofpapers (30,45-48).
Among the mechanisms that have been
proposed for an EMF effect on mammary
tumor development (37), the one with the
shortest expected latency period is an EMF-
induced disruption ofmelatonin's oncosta-
tic action. Liburdy et al. (49) reported that a
12-mG 60-Hz magnetic field could reverse
the growth inhibition ofMCF-7 mammary
cancer cells by melatonin in vitro. This is
the only report thus far on this potential
mechanism and deserves to be pursued in
additional independent laboratories.
The direct laboratory evidence is still
quite limited but is clearly provocative and
important to pursue. This experimental
evidence provides direct support for the
biological rationale for examining a possi-
ble influence of EMF exposure on risk of
breast cancer in women.
Epidemiological Evidence
If LAN increases risk of breast cancer in
sighted women, Hahn (50) reasoned that
profoundly blind women, who do not per-
ceive LAN, would be at reduced risk. He
analyzed over 100,000 hospital discharge
records published by the National Hospital
Discharge Survey to determine how fre-
quently there was a diagnosis ofprofound
bilateral blindness in women also diag-
nosed with breast cancer compared to con-
trol women with diagnoses of stroke or
cardiovascular disease. Among the control
women, 0.26% were also blind, which is
approximately the percentage expected on
the basis ofnational surveys ofnonhospi-
talized women. Among the women with
breast cancer, however, only 0.15% were
also blind; this was consistent with Hahn's
prediction. Hahn adjusted for diabetes
and marital status, but the adjustment
depended on complete data in the medical
records. The effect of blindness was
strongest in young women.
The first epidemiological studies to
address the EMF and breast cancer hypoth-
esis were ofoccupational exposure in men.
In a large study of telephone workers in
New York State, Matanoski et al. (51)
found two cases of breast cancer among
men in one offour occupations defined as
having probable high EMF exposure; none
were expected (a small fraction of a case
was expected). This report was followed by
a case-control study from the United
States (52) and a cohort study that used
the entire working population ofNorway
(53). Both ofthese studies also reported an
excess ofbreast cancer among men in occu-
pations thought to entail high EMF expo-
sure; however, other studies have seen no
relationship ofoccupational exposure and
risk in men (54,55).
Guenel et al. (56) in Denmark and
Vagero and Olin (57) in Sweden both
reported no association ofEMF occupation
and breast cancer risk in women. However,
there may have been extensive exposure
misclassification. The definitions of EMF
exposure occupations for women were
broad. Vagero and Olin (57) classified
about 2.6% ofmen and 2% ofwomen in
Sweden as being in exposed occupations.
This was broadly defined as the electronics
or electrical manufacturing industry.
Guenel et al. (56) classified about 1.7% of
men and 0.61% ofwomen as continuously
exposed and 14.5% ofmen and 12.6% of
women as intermittently exposed.
Loomis et al. (58) conducted an occu-
pational study of breast cancer death in
women in the United States. There was a
significant excess ofbreast cancer deaths in
women working in electrical occupations
in contrast to Guenel et al. (56) and
Vagero and Olin (57). There are differ-
ences in the studies. In the U.S. study,
women were classified as exposed if they
worked in jobs that had been previously
used to classify men in exposed occupa-
tions ofleukemia and brain cancer studies.
In the Loomis et al. (58) study population,
0.18% ofwomen were in those occupations,
whereas 2.6% ofthe U.S. male workforce
are in those same occupations. It is this
group ofwomen that showed the significant
elevation. An additional group ofpossible
exposed occupations made up only 2% of
women, and among these there was not a
significant elevation ofbreast cancer risk.
It is difficult to determine ifan occupa-
tional study of a ubiquitous exposure and
common disease is strong evidence because
even those people in occupations defined as
unexposed are certainly not unexposed to
anthropogenic EMF. In addition, the
background risk ofbreast cancer in women
is high, and any real effect of EMF that
may exist in the population may not
respond to the additional exposures
entailed in occupations with higher than
average exposure.
In 1991, Vena et al. (59) reported that
use ofelectric blankets was not associated
with risk ofbreast cancer in postmenopausal
women. In 1994, they reported no associa-
tion in premenopausal women from the
same case-control study ofwomen in west-
ern New York State (60). These studies
have been cited as unbiased tests of the
EMF hypothesis, although they do not
support it (55). In both publications, how-
ever, the risk forwomen who reported using
electric blankets throughout the night was
approximately 1.4 (1.43 for premenopausal
women and 1.46 for postmenopausal
women). In response to a request by Stevens
(61), Vena et al. (62) have presented a com-
bined analysis ofall women in the study.
The odds ratio is 1.45 (p< 0.01; 95% CI of
1.08-1.94) for women using electric blan-
kets throughout the night after adjustment
by logistic regression for age, education,
age at first pregnancy, number ofpregnan-
cies, age at menarche, relative with breast
cancer, Quetelet index, history ofbenign
breast disease, and menopausal status.
There are at least three possible inter-
pretations of the modest odds ratio and
highly statistically significant results of
Vena et al. (62): this is a spurious finding
never to be seen again, a real association
that is explained by confounding, or a real
association explained by magnetic field
exposure. If the elevated risk ratio results
from EMF,.then it may be an underesti-
mate ofthe true effect ofexposure because
the "never user" comparison group is not
unexposed to anthropogenic EMF. In any
event, the Vena et al. study (62) is not
strong evidence eitherway.
Plausibility
The melatonin hypothesis for electric
power and breast cancer stands on a three-
legged stool: light effects on melatonin
production, EMF effects on melatonin pro-
duction, and the role ofmelatonin in breast
cancer etiology. There is as yet very little
direct evidence, either experimental or epi-
demiological (as described above). Table 1
shows the strength of the evidence at the
date ofthis writing.
The strongest leg of the stool is the
effects of light on melatonin. It is clear
from the published evidence that light of
sufficient intensity suppresses the normal
nocturnal melatonin peak in all people so
far tested, that there are large differences
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Table 1. Strength of the direct evidence and of each
aspect of the circumstantial case forthe electric power
and breast cancer hypothesis.
Question Evidence
Direct evidence Sparse
Light effect on melatonin
In animals Solid
In humans Strong
EMF effect on melatonin
In animals Mounting
In humans Very little
Melatonin effect on breast cancer
In animals Strong
In humans Unclear
among people in their light sensitivity at
night, and that there appears to be a dose
response to light. It remains unclear
whether ambient night-time light levels or
briefexposure to bright lights at night affect
melatonin in any significant proportion of
the population at large; this is the subject
ofcurrent research.
The effect of melatonin on breast
cancer can be strong in experimental ani-
mals but is quite unclear in humans.
Melatonin inhibits the development of
both DMBA- and NMU-induced breast
cancer in rats, whereas pinealectomy
enhances tumor development. This obser-
vation does not define the mechanism by
which melatonin affects breast cancer at
the cellular or tissue level. Other evidence
has shown melatonin to be oncostatic to
certain subclones ofMCF-7 cell lines and
to affect estrogen and prolactin levels and
the development ofthe breast epithelial tis-
sue at risk. Whatever the mechanism of
action may be, melatonin can have a strong
influence on breast cancer in rats. For
humans, however, the evidence is sparse
and exceedingly difficult to gather. Stored
serum banks are often used to test etiologic
hypotheses for hormones or micronutrients
but are virtually useless for studies of
melatonin because the blood was drawn
during the day when melatonin is at its
lowest. Use of stored prediagnosis morn-
ing-urine samples may make epidemiologi-
cal studies ofmelatonin and breast cancer
possible. There is evidence that the level of
6-hydroxy-melatonin sulphate, the primary
metabolite of melatonin, in the morning
void reflects the total nocturnal production
ofmelatonin very well (63). There is evi-
dence that women with ER+ breast cancer
have lower night-time melatonin than con-
trol women or women with ER- breast
cancer, but the disease may well affect
melatonin production.
The weakest leg is EMF effects on
melatonin. In animals, at least six indepen-
dent laboratories have published results
wherein a low intensity electric or magnetic
field suppresses melatonin. Few of the
experiments are directly comparable in that
some labs have used 50- or 60-Hz magnetic
fields, some have used rapid changes in
earth-strength static magnetic fields, and
some have used 60-Hz electric fields. There
have been conflicting reports and some care-
fully executed experiments have shown no
effects. To date, reported experiments have
either shown suppression or no effect;
there are no reports to our knowledge of a
stimulation ofmelatonin by a low-intensity
EMF exposure. The weight of evidence is
that, under some circumstances in certain
experimental settings, EMF can suppress
melatonin. There are no published data on
humans. Three laboratories have per-
formed experiments in humans with
inconsistent results. Ifeffects are found in
the laboratory, this does not necessarily
mean there are effects in the typical home
and work environment ofpeople. Several
studies are currently addressing that possi-
bility by the use ofportable meters and
assessment of melatonin by assay of the
primary urinary metabolite.
Direct evidence is also being gener-
ated; this includes epidemiological studies
designed to test the electric power
hypothesis and laboratory experiments to
replicate the Loscher results. If the direct
evidence accumulates to the point of
strongly supporting a LAN- or EMF-
induced elevation of risk of breast cancer
in women, then understanding the mech-
anism would offer possible mitigation
strategies. Melatonin would be an appeal-
ing mechanism but would not rule out
some other as yet unsuspected mechanism
as being responsible.
Conclusion and
Future Directions
At present, the hypothesis that LAN or
EMF from the use of electric power
increases risk of breast cancer remains
quite speculative. Although the indirect
evidence provides a rationale, the direct
evidence is inadequate to draw a conclusion
on the subject. Direct evidence is being
gathered at a rapid pace and might well
lead to resolution within 5 years; because
breast cancer is so common in the indus-
trialized world, many large studies can be
conducted simultaneously.
Future directions include an investiga-
tion ofprostate cancer (64) in men based
on a similar, though more speculative, line
ofreasoning (37).
The generation and distribution of
electric power has made our modern life
and building environments possible.
Among the most profound environmental
consequences ofelectrification is exposure
to light at night and to light of a different
character than sunlight during the day.
Since the vast majority ofpeople in indus-
trialized societies work in buildings and
virtually all people sleep in buildings, the
long-term health effect of the indoor-
lighted environment deserves attention,
particularly in terms ofchronic disruption
ofmelatonin rhythms (65,66).
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